MDxHealth (MDXH) Payables (2020 - 2026)

MDxHealth has reported Payables for 7 years, with the latest figure at $12.1 million in Q1 2026.

• Quarterly Payables rose 59.84% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 59.84% YoY) and the FY2025 annual result came in at $10.3 million, up 29.11% from the prior year.
• Payables climbed to $12.1 million in Q1 2026 per MDXH's latest filing, from $10.3 million in the prior quarter.
• Over five years, Payables peaked at $7.7 billion in Q2 2025 and troughed at $7.6 million in Q1 2025.
• A 5-year average of $519.6 million and a median of $10.2 million in 2022 frame the typical range for Payables.
• The sharpest annual moves came in 2023 and 2025: Payables declined 25.56% in 2023, then soared 63024.95% in 2025.
• Over 5 years, Payables stood at $10.2 million in 2022, then fell by 13.43% to $8.8 million in 2023, then slipped by 9.19% to $8.0 million in 2024, then climbed by 29.11% to $10.3 million in 2025, then rose by 16.85% to $12.1 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $12.1 million, $10.3 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.